| Nanobodies: The “magic bullets” in therapeutics, drug delivery and diagnostics MA Mir, U Mehraj, BA Sheikh, SS Hamdani Human antibodies 28 (1), 29-51, 2020 | 58 | 2020 |
| Development of new therapeutics to meet the current challenge of drug resistant tuberculosis BA Sheikh, BA Bhat, U Mehraj, W Mir, S Hamadani, MA Mir Current pharmaceutical biotechnology 22 (4), 480-500, 2021 | 41 | 2021 |
| Recent advances in metabolites from medicinal plants in cancer prevention and treatment MA Mir, SS Hamdani, BA Sheikh, U Mehraj Current Immunology Reviews 15 (2), 185-201, 2019 | 25 | 2019 |
| In vitro and in silico evaluation of antimicrobial properties of Delphinium cashmerianum L., a medicinal herb growing in Kashmir, India BA Bhat, WR Mir, BA Sheikh, MA Rather, MA Mir Journal of Ethnopharmacology 291, 115046, 2022 | 20 | 2022 |
| Recent advances in chemotherapeutic implications of deguelin: a plant-derived retinoid MA Mir, U Mehraj, BA Sheikh The Natural Products Journal 11 (2), 169-181, 2021 | 17 | 2021 |
| Antimicrobial resistance: new insights and therapeutic implications BA Sheikh, BA Bhat, MA Mir Applied Microbiology and Biotechnology 106 (19-20), 6427-6440, 2022 | 16 | 2022 |
| Metabolite fingerprinting of phytoconstituents from Fritillaria cirrhosa D. Don and molecular docking analysis of bioactive peonidin with microbial drug target proteins BA Bhat, WR Mir, BA Sheikh, M Alkanani, MA Mir Scientific Reports 12 (1), 7296, 2022 | 16 | 2022 |
| Nano-drug delivery systems: Possible end to the rising threats of tuberculosis BA Sheikh, BA Bhat, B Alshehri, RA Mir, WR Mir, ZA Parry, MA Mir Journal of Biomedical Nanotechnology 17 (12), 2298-2318, 2021 | 12 | 2021 |
| Nanomedicine in human health therapeutics and drug delivery: nanobiotechnology and nanobiomedicine MA Mir, BA Bhat, BA Sheikh, GA Rather, S Mehraj, WR Mir Applications of nanomaterials in agriculture, food science, and medicine …, 2021 | 12 | 2021 |
| Strategies employed to evade the host immune response and the mechanism of drug resistance in Mycobacterium tuberculosis: In search of finding new targets BA Sheikh, BA Bhat, Z Ahmad, MA Mir Current pharmaceutical biotechnology 23 (14), 1704-1720, 2022 | 9 | 2022 |
| Computational studies to identify potential inhibitors targeting the DPRE1 protein in Mycobacterium tuberculosis BA Sheikh, BA Bhat, MA Rizvi, Z Ahmad, A Almilaibary, M Alkhanani, ... International Journal of Pharmaceutical Investigation 13 (1), 129-138, 2022 | 3 | 2022 |
| Antioxidants (natural and synthetic) screening assays: An overview BA Bhat, S Nisar, BA Sheikh, WR Mir, MA Mir Bentham Briefs in Biomedicine and Pharmacotherapy Oxidative Stress and …, 2021 | 3 | 2021 |
| Gell and coomb’s classification of hypersensitivity NA Wani, MA Mir, H Qayoom, U Mehraj, S Nisar, BA Sheikh, S Suhail The Fundamentals of Hypersensitivities and Allergies; Nova Science …, 2020 | 2 | 2020 |
| Hypersensitivity reaction MA Mir, U Mehraj, S Nisar, BA Sheikh, S Suhail, H Qayoom The Fundamentals of Hypersensitivities and Allergies; Nova Science …, 2020 | 2 | 2020 |
| A Novel Prognostic Biomarker with Potential of High Diagnostic Accuracy in Pulmonary Tuberculosis: An in silico Study. BA Sheikh, BA Bhat, RA Mir, Z Ahmad, MA Mir International Journal of Pharmaceutical Investigation 12 (2), 2022 | 1 | 2022 |
| ORGANS OF THE IMMUNE SYSTEM U Mehraj, S Nisar, BA Bhat, BA Sheikh, SS Hamdani, H Qayoom, MA Mir BASICS AND FUNDAMENTALS OF IMMUNOLOGY, 53, 0 | 1 | |
| Cells of the immune system U Mehraj, S Nisar, SS Hamdani, BA Sheikh, BA Bhat, H Qayoom, MA Mir Basics Fundam Immunol 25, 0 | 1 | |
| TYPE IV HYPERSENSITIVITY (DELAYED TYPE HYPERSENSITIVITY) NA Wani, S Suhail, H Qayoom, S Nisar, BA Sheikh, U Mehraj, MA Mir THE FUNDAMENTALS OF HYPERSENSITIVITIES AND ALLERGIES, 161, 0 | 1 | |
| INTRODUCTION TO IMMUNOLOGY S Nisar, U Mehraj, BA Sheikh, SS Hamdani, H Qayoom, BA Bhat, MA Mir BASICS AND FUNDAMENTALS OF IMMUNOLOGY, 1, 0 | | |
| TYPE IHypersensitivity (ALLERGY OR IMMEDIATE TYPE HYPERSENSITIVITY) NA Wani, MA Mir, H Qayoom, U Mehraj, S Nisar, BA Sheikh, S Suhail THE FUNDAMENTALS OF HYPERSENSITIVITIES AND ALLERGIES, 75, 0 | | |
